Literature DB >> 19237604

Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.

Melanie Adler1, Katja Müller, Eva Rached, Wolfgang Dekant, Angela Mally.   

Abstract

Ochratoxin A (OTA) is a potent renal carcinogen, but little is known regarding the mechanism of OTA carcinogenicity. Early histopathological alterations induced by OTA in rat kidney include single cell death, stimulation of cell proliferation and prominent karyomegaly indicative of blocked nuclear division during mitosis. Based on these observations, it has been suggested that disruption of mitosis by OTA may be the principal cause of cell death and subsequent trigger for cell proliferation to compensate for cell loss. To gain further insight into the molecular mechanism of OTA toxicity, we used targeted quantitative real-time polymerase chain reaction arrays to investigate the expression of genes involved in cell cycle control and mitosis in kidneys of male F344 rats treated with 0, 21, 70 and 210 microg/kg body wt OTA for up to 90 days. Treatment with OTA resulted in overexpression of key regulators of mitosis, including the mitotic protein kinases Polo-like kinase 1, Aurora B and cyclin-dependent kinase 1 (Cdk1Cdc2), several cyclins and cyclin-dependent kinase inhibitors, topoisomerase II and survivin. Immunohistochemical analysis confirmed upregulation of Cdk1, p21(WAF1/CIP1), topoisomerase II and survivin in S3 proximal tubule cells, from which OTA-induced tumors in rats arise, and demonstrated increased phosphorylation of histone H3, a target of Aurora B. Importantly, many of the genes found to be deregulated in response to OTA have been linked to chromosomal instability and malignant transformation, supporting the hypothesis that aberrant mitosis, resulting in blocked or asymmetric cell division, accompanied by an increased risk of aneuploidy acquisition, may play a critical role in OTA carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237604     DOI: 10.1093/carcin/bgp049

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Authors:  Masayoshi Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

2.  Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin a toxicity and carcinogenicity?

Authors:  Kristin Czakai; Katja Müller; Pasquale Mosesso; Gaetano Pepe; Markus Schulze; Antje Gohla; Debasis Patnaik; Wolfgang Dekant; Jonathan M G Higgins; Angela Mally
Journal:  Toxicol Sci       Date:  2011-05-06       Impact factor: 4.849

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery.

Authors:  D-W Yan; D-W Li; Y-X Yang; J Xia; X-L Wang; C-Z Zhou; J-W Fan; Y-G Wen; H-C Sun; Q Wang; G-Q Qiu; H-M Tang; Z-H Peng
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

Review 5.  A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model.

Authors:  Lois A Haighton; Barry S Lynch; Bernadene A Magnuson; Earle R Nestmann
Journal:  Crit Rev Toxicol       Date:  2012-02       Impact factor: 5.635

Review 6.  In-Vitro Cell Culture for Efficient Assessment of Mycotoxin Exposure, Toxicity and Risk Mitigation.

Authors:  Ran Xu; Niel A Karrow; Umesh K Shandilya; Lv-Hui Sun; Haruki Kitazawa
Journal:  Toxins (Basel)       Date:  2020-02-27       Impact factor: 4.546

7.  Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.

Authors:  Chia-Lin Chou; Tzu-Ju Chen; Wan-Shan Li; Sung-Wei Lee; Ching-Chieh Yang; Yu-Feng Tian; Cheng-Yi Lin; Hong-Lin He; Hung-Chang Wu; Yow-Ling Shiue; Chien-Feng Li; Yu-Hsuan Kuo
Journal:  Onco Targets Ther       Date:  2022-10-11       Impact factor: 4.345

Review 8.  Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level.

Authors:  Tamás Kőszegi; Miklós Poór
Journal:  Toxins (Basel)       Date:  2016-04-15       Impact factor: 4.546

Review 9.  Mycotoxins' Toxicological Mechanisms Involving Humans, Livestock and Their Associated Health Concerns: A Review.

Authors:  Chinaza Godseill Awuchi; Erick Nyakundi Ondari; Sarah Nwozo; Grace Akinyi Odongo; Ifie Josiah Eseoghene; Hannington Twinomuhwezi; Chukwuka U Ogbonna; Anjani K Upadhyay; Ademiku O Adeleye; Charles Odilichukwu R Okpala
Journal:  Toxins (Basel)       Date:  2022-02-24       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.